670 related articles for article (PubMed ID: 31941663)
1. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
2. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
3. The majority of A-to-I RNA editing is not required for mammalian homeostasis.
Chalk AM; Taylor S; Heraud-Farlow JE; Walkley CR
Genome Biol; 2019 Dec; 20(1):268. PubMed ID: 31815657
[TBL] [Abstract][Full Text] [Related]
4. Substrate recognition by ADAR1 and ADAR2.
Wong SK; Sato S; Lazinski DW
RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
[TBL] [Abstract][Full Text] [Related]
5. Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects.
Keegan LP; McGurk L; Palavicini JP; Brindle J; Paro S; Li X; Rosenthal JJ; O'Connell MA
Nucleic Acids Res; 2011 Sep; 39(16):7249-62. PubMed ID: 21622951
[TBL] [Abstract][Full Text] [Related]
6. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
[TBL] [Abstract][Full Text] [Related]
7. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
[TBL] [Abstract][Full Text] [Related]
8. Comparative Activity of Adenosine Deaminase Acting on RNA (ADARs) Isoforms for Correction of Genetic Code in Gene Therapy.
Azad MTA; Qulsum U; Tsukahara T
Curr Gene Ther; 2019; 19(1):31-39. PubMed ID: 30426900
[TBL] [Abstract][Full Text] [Related]
9. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
Keegan LP; Hajji K; O'Connell MA
Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
[TBL] [Abstract][Full Text] [Related]
10. ADAR RNA editing in human disease; more to it than meets the I.
Gallo A; Vukic D; Michalík D; O'Connell MA; Keegan LP
Hum Genet; 2017 Sep; 136(9):1265-1278. PubMed ID: 28913566
[TBL] [Abstract][Full Text] [Related]
11. ADAR1 and ADAR2 expression and editing activity during forebrain development.
Jacobs MM; Fogg RL; Emeson RB; Stanwood GD
Dev Neurosci; 2009; 31(3):223-37. PubMed ID: 19325227
[TBL] [Abstract][Full Text] [Related]
12. Specificity of ADAR-mediated RNA editing in newly identified targets.
Riedmann EM; Schopoff S; Hartner JC; Jantsch MF
RNA; 2008 Jun; 14(6):1110-8. PubMed ID: 18430892
[TBL] [Abstract][Full Text] [Related]
13. Editing independent effects of ADARs on the miRNA/siRNA pathways.
Heale BS; Keegan LP; McGurk L; Michlewski G; Brindle J; Stanton CM; Caceres JF; O'Connell MA
EMBO J; 2009 Oct; 28(20):3145-56. PubMed ID: 19713932
[TBL] [Abstract][Full Text] [Related]
14. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
[TBL] [Abstract][Full Text] [Related]
15. ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism.
Widmark A; Sagredo EA; Karlström V; Behm M; Biryukova I; Friedländer MR; Daniel C; Öhman M
J Biol Chem; 2022 Mar; 298(3):101682. PubMed ID: 35124003
[TBL] [Abstract][Full Text] [Related]
16. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.
Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR
Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170
[TBL] [Abstract][Full Text] [Related]
17. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
Lehmann KA; Bass BL
Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
[TBL] [Abstract][Full Text] [Related]
18. Cell death following the loss of ADAR1 mediated A-to-I RNA editing is not effected by the intrinsic apoptosis pathway.
Walkley CR; Kile BT
Cell Death Dis; 2019 Dec; 10(12):913. PubMed ID: 31801951
[TBL] [Abstract][Full Text] [Related]
19. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
[TBL] [Abstract][Full Text] [Related]
20. ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations.
Hajji K; Sedmík J; Cherian A; Amoruso D; Keegan LP; O'Connell MA
RNA; 2022 Oct; 28(10):1281-1297. PubMed ID: 35863867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
